Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1985 1
1986 4
1987 1
1989 1
1990 4
1991 1
1992 2
1993 3
1994 1
1995 1
1996 3
1997 1
1998 3
1999 2
2000 3
2001 4
2002 3
2003 4
2004 2
2005 6
2006 3
2007 13
2008 9
2009 8
2010 7
2011 15
2012 17
2013 10
2014 14
2015 17
2016 15
2017 13
2018 11
2019 5
2020 7
2021 16
2022 8
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
Dinh A, Ropers J, Duran C, Davido B, Deconinck L, Matt M, Senard O, Lagrange A, Makhloufi S, Mellon G, de Lastours V, Bouchand F, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Renaud B, Perronne C, Claessens YE, Labarère J, Bedos JP, Aegerter P, Crémieux AC; Pneumonia Short Treatment (PTC) Study Group. Dinh A, et al. Among authors: aegerter p. Lancet. 2021 Mar 27;397(10280):1195-1203. doi: 10.1016/S0140-6736(21)00313-5. Lancet. 2021. PMID: 33773631 Clinical Trial.
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial.
Planquette B, Bertoletti L, Charles-Nelson A, Laporte S, Grange C, Mahé I, Pernod G, Elias A, Couturaud F, Falvo N, Sevestre MA, Ray V, Burnod A, Brebion N, Roy PM, Timar-David M, Aquilanti S, Constans J, Bura-Rivière A, Brisot D, Chatellier G, Sanchez O, Meyer G, Girard P, Mismetti P; CASTA DIVA Trial Investigators. Planquette B, et al. Chest. 2022 Mar;161(3):781-790. doi: 10.1016/j.chest.2021.09.037. Epub 2021 Oct 8. Chest. 2022. PMID: 34627853 Clinical Trial.
Reliability of a consensus-based ultrasound definition and scoring for enthesitis in spondyloarthritis and psoriatic arthritis: an OMERACT US initiative.
Balint PV, Terslev L, Aegerter P, Bruyn GAW, Chary-Valckenaere I, Gandjbakhch F, Iagnocco A, Jousse-Joulin S, Möller I, Naredo E, Schmidt WA, Wakefield RJ, D'Agostino MA; OMERACT Ultrasound Task Force members. Balint PV, et al. Among authors: aegerter p. Ann Rheum Dis. 2018 Dec;77(12):1730-1735. doi: 10.1136/annrheumdis-2018-213609. Epub 2018 Aug 3. Ann Rheum Dis. 2018. PMID: 30076154
Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene.
Stheneur C, Collod-Béroud G, Faivre L, Buyck JF, Gouya L, Le Parc JM, Moura B, Muti C, Grandchamp B, Sultan G, Claustres M, Aegerter P, Chevallier B, Jondeau G, Boileau C. Stheneur C, et al. Among authors: aegerter p. Eur J Hum Genet. 2009 Sep;17(9):1121-8. doi: 10.1038/ejhg.2009.36. Epub 2009 Mar 18. Eur J Hum Genet. 2009. PMID: 19293843 Free PMC article.
Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring system.
D'Agostino MA, Terslev L, Aegerter P, Backhaus M, Balint P, Bruyn GA, Filippucci E, Grassi W, Iagnocco A, Jousse-Joulin S, Kane D, Naredo E, Schmidt W, Szkudlarek M, Conaghan PG, Wakefield RJ. D'Agostino MA, et al. Among authors: aegerter p. RMD Open. 2017 Jul 11;3(1):e000428. doi: 10.1136/rmdopen-2016-000428. eCollection 2017. RMD Open. 2017. PMID: 28948983 Free PMC article.
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial.
Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru JP, Therby A, Bouhour D, Dénes E, Debard A, Chirouze C, Fèvre K, Dupon M, Aegerter P, Mulleman D; Duration of Treatment for Spondylodiscitis (DTS) study group. Bernard L, et al. Among authors: aegerter p. Lancet. 2015 Mar 7;385(9971):875-82. doi: 10.1016/S0140-6736(14)61233-2. Epub 2014 Nov 5. Lancet. 2015. PMID: 25468170 Clinical Trial.
Hippo Signaling Pathway in Pancreas Development.
Wu Y, Aegerter P, Nipper M, Ramjit L, Liu J, Wang P. Wu Y, et al. Among authors: aegerter p. Front Cell Dev Biol. 2021 May 17;9:663906. doi: 10.3389/fcell.2021.663906. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34079799 Free PMC article. Review.
Response.
Saiag P, Aegerter P, Boniol M. Saiag P, et al. Among authors: aegerter p. J Natl Cancer Inst. 2016 Feb 23;108(4):djw015. doi: 10.1093/jnci/djw015. Print 2016 Apr. J Natl Cancer Inst. 2016. PMID: 26912670 Free article. No abstract available.
The authors reply.
Dres M, Tran TC, Aegerter P, Rabbat A, Guidet B, Huchon G, Roche N. Dres M, et al. Among authors: aegerter p. Crit Care Med. 2014 Mar;42(3):e250. doi: 10.1097/CCM.0000000000000153. Crit Care Med. 2014. PMID: 24534989 No abstract available.
220 results